Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
InChiKey: LKJPYSCBVHEWIU-UHFFFAOYSA-N
Successful Treatment of Bowen's Disease with Topical Maxacalcitol
Mirdametinib
8-tetrahydronaphthalen-2-yl]-1
Modification of sphingolipid metabolism by tamoxifen and N-desmethyltamoxifen in acute myelogenous leukemia--Impact on enzyme activity and response to cytotoxics
B-HT 920 - CAS# 36085-73-1 Size:Solid 10 mg InChiKey: LKJPYSCBVHEWIU-UHFFFAOYSA-NTalipexole, also known as B HT920 and Domnin, is a dopamine agonist that is marketed as a treatment for Parkinson's Disease in Japan by Boehringer Ingelheim; it was introduced in 1996. As of December 2014 it was not approved for marketing in the US nor in Europe. Talipexole is a D2 dopamine receptor agonist and interacts both pre and post synaptic receptors. It also is an 2 adrenergic agonist. The main side effects are drowsiness, dizziness,
US$ 34.81
US$ 100.69
US$ 103.75
US$ 70.00
US$ 710.51
US$ 1277.38
US$ 25.10